Julie Dubois

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

Arnon P. Kater, Jenny Wu, Thomas J. Kipps et al. · Journal of Clinical Oncology · 2020 · 220 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre

Mégane Jermini, Julie Dubois, Pierre‐Yves Rodondi et al. · Scientific Reports · 2019 · 129 citations · Full text

Medicine, Oncology, Pharmacology +12

World Congress Integrative Medicine & Health 2017: Part one

Torkel Falkenberg, Stefan N. Willich, Josephine P. Briggs et al. · BMC Complementary and Alternative Medicine · 2017 · 116 citations · Full text

Health Professions, Health Sciences, Clinical Medicine +6

Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL

Marco V. Haselager, Karoline Kielbassa, Johanna ter Burg et al. · Blood · 2020 · 116 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Iris de Weerdt, Tom Hofland, Renate de Boer et al. · Blood Advances · 2019 · 107 citations · Full text

Life Sciences, Hematology, Immunology +17